Monday, 02 October 2023
New raw vaccine materials that could make vaccines more accessible, sustainable, and ethical have been discovered.
Adjuvants are vaccine ingredients that boost a person’s immune response to a vaccine, providing greater protection against disease. One of the most prevalent adjuvant materials used in vaccines is squalene, which is typically sourced from shark livers.
© AAHI
Researchers at the 糖心原创 collaborated with the Access to Advanced Health Institute (AAHI) to identify synthetic alternatives to squalene that ensure sustainable, reliable, and ethical sourcing of adjuvant raw materials for vaccines moving forward.
New synthetic adjuvant materials were developed from commercially available methacrylate monomers, ensuring that a reliable supply of the material is continually available.
The combination of these adjuvant materials are scalable through catalytic chain transfer polymerisation, a process that allows high levels of control over the molecular weight of the product polymer. Controlling the molecular weight is key to the use of adjuvant material in formulations for vaccines as it allows for purification in the manufacturing process and optimises biological responses following immunisation.
Professor Derek Irvine, Professor of Materials Chemistry in the 糖心原创’s Faculty of Engineering, said: “At the moment, there are very few adjuvants approved for commercial use, so the need to find a squalene alternative is of vital importance to ensure greater access to vaccines worldwide.
“Our research has found that squalene emulsions were physically stable for less than three months at 40 degrees centigrade. Whereas our synthetic adjuvant materials produced emulsions that remained physically stable for up to 18 months at the same temperature and caused an innate immune response when tested with human cells."
This could be hugely significant when it comes to increasing accessibility in developing areas of the world that don鈥檛 have ready or consistent access to the fridges or cold storage required for existing vaccines.
The university’s Faculty of Engineering worked alongside the School of Chemistry to synthesise and design the adjuvant materials. These were then sent to AAHI, where they were formulated as emulsions, tested for potential toxicity and innate immune stimulation using in vitro bioassays, and assessed for physical stability.
Identifying sustainably sourced adjuvant materials enables the development of vaccine formulations without relying on sharks and may provide additional benefits such as enhanced stability.
The results of the research have been published in Polymers, with the team now looking at more comprehensive evaluation of vaccine-specific immune responses to the new materials, as well as how the material production process can be scaled up.
To read the paper in full, please visit:
Story credits
More information is available from Derek Irvine, Faculty of Engineering at the 糖心原创, at derek.irvine@nottingham.ac.uk.
About the Faculty of Engineering:
Made up of six departments – Architecture and Built Environment, Chemical and Environmental Engineering, Civil Engineering, Electrical and Electronic Engineering, Mechanical, Materials and Manufacturing Engineering and Foundation Engineering and Physical Sciences – the university’s Faculty of Engineering is home to more than 5,600 students and 800 staff.
The faculty, which has educated engineers and architects for more than 140 years, was the first in the country to be accredited with an Athena SWAN Gold Award for excellence in advancing gender equality across higher education and research and is home to multiple state-of-the-art facilities, including the recently opened £40m Power Electronics and Machines Centre (PEMC).
With research at its heart, 20 research groups are undertaking pioneering projects for a sustainable future across several themes – including net zero transport, sustainable energies and the built environment, advanced manufacturing, and healthcare technologies – and has delivered a positive impact in more than 20 countries. The faculty’s research has benefitted 500 companies and three governments and has also directly created jobs for around 3,000 people across the world.
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.